- Home
- SHCO vs SANA Comparison
SHCO vs SANA Comparison
Compare SHCO & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHCO
- SANA
- Stock Information
- Founded
- SHCO 1995
- SANA 2018
- Country
- SHCO United Kingdom
- SANA United States
- Employees
- SHCO N/A
- SANA N/A
- Industry
- SHCO Hotels/Resorts
- SANA Medicinal Chemicals and Botanical Products
- Sector
- SHCO Consumer Discretionary
- SANA Health Care
- Exchange
- SHCO Nasdaq
- SANA Nasdaq
- Market Cap
- SHCO 1.0B
- SANA 983.4M
- IPO Year
- SHCO 2021
- SANA 2021
- Fundamental
- Price
- SHCO $6.32
- SANA $3.91
- Analyst Decision
- SHCO Buy
- SANA Strong Buy
- Analyst Count
- SHCO 2
- SANA 6
- Target Price
- SHCO $7.25
- SANA $10.00
- AVG Volume (30 Days)
- SHCO 292.2K
- SANA 5.5M
- Earning Date
- SHCO 08-12-2025
- SANA 08-11-2025
- Dividend Yield
- SHCO N/A
- SANA N/A
- EPS Growth
- SHCO N/A
- SANA N/A
- EPS
- SHCO N/A
- SANA N/A
- Revenue
- SHCO $1,224,734,000.00
- SANA N/A
- Revenue This Year
- SHCO $8.99
- SANA N/A
- Revenue Next Year
- SHCO $6.02
- SANA N/A
- P/E Ratio
- SHCO N/A
- SANA N/A
- Revenue Growth
- SHCO 8.21
- SANA N/A
- 52 Week Low
- SHCO $4.43
- SANA $1.26
- 52 Week High
- SHCO $8.47
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- SHCO 36.53
- SANA 47.52
- Support Level
- SHCO $6.30
- SANA $4.72
- Resistance Level
- SHCO $6.58
- SANA $5.33
- Average True Range (ATR)
- SHCO 0.26
- SANA 0.35
- MACD
- SHCO -0.06
- SANA -0.14
- Stochastic Oscillator
- SHCO 19.42
- SANA 3.40
About SHCO Soho House & Co Inc.
Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.